trending Market Intelligence /marketintelligence/en/news-insights/trending/6vsc9qd-f_izybu_il-inq2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Zoetis-Abaxis deal receives antitrust clearance


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates

Zoetis-Abaxis deal receives antitrust clearance

Zoetis Inc. said its previously announced acquisition of Abaxis Inc. received antitrust clearance under the Hart-Scott-Rodino Act.

The transaction is subject to other customary closing conditions, including approval from Abaxis shareholders, who will vote on the deal at a July 31 special meeting.

The Parsippany, N.J.-based animal health company said it expects to close the deal shortly after the Abaxis meeting. Zoetis added that it plans to pay for the acquisition through existing cash and new debt.

Union City, Calif.-based Abaxis makes and sells portable blood analysis systems for use in human or veterinary patient care.